Janine Schuurman PhD
Immunology and Microbiology
Utrecht, Utrecht, Netherlands
Connect with the speaker?
Dr. Janine Schuurman is an expert in antibody biology and translational research. Following her passion to develop innovative antibody therapeutics, Dr. Schuurman joined Genmab in 2000. She currently serves in the position of Corporate Vice President Research & Innovation in which she heads Research and Technologies, focusing on antibody biology research, the creation of novel antibody formats and their translation to antibody therapeutics.
She is a co-inventor of the DuoBody, HexaBody and HexElect technologies that enable the generation of bispecific and effector-function enhanced antibodies. These technologies are being applied to antibody therapeutics discovery programs at Genmab, as well as many leading pharmaceutical and biotechnology companies located worldwide.
She is a co-inventor of the DuoBody, HexaBody and HexElect technologies that enable the generation of bispecific and effector-function enhanced antibodies. These technologies are being applied to antibody therapeutics discovery programs at Genmab, as well as many leading pharmaceutical and biotechnology companies located worldwide.
EVENTS & ACTIVITIES (Speaking, Spoken, and Authored)
9th World Bispecific Summit
In-Person Event
Sep 18 - 20, 2018
Boston, Massachusetts, USA
Antibodies as Drugs: Translating Molecules into Treatments (C1)
- In-Person Event
Pharmacy and Medicine ...- Feb 25 - Mar 01, 2018
- Whistler, British Columbia, CA
World Bispecific Summit
- In-Person Event
- Sep 28 - 30, 2016
- Boston, Massachusetts, USA
Quick Links
- 50 Division Street, Suite 501,
- Somerville, NJ 08876
- support@emedevents.com